Morphic Therapeutic Overview

  • Founded
  • 2014
Founded
  • Status
  • Public
  • Employees
  • 83
Employees
  • Stock Symbol
  • MORF
Stock Symbol
  • Share Price
  • $32.37
  • (As of Tuesday Closing)

Morphic Therapeutic General Information

Description

Morphic Holding Inc is a biopharmaceutical company applying its insights into integrins to discover and develop a pipeline of oral small-molecule integrin therapeutics. Integrins are a target class with multiple approved injectable blockbuster drugs for the treatment of serious chronic diseases, including autoimmune, cardiovascular and metabolic diseases, fibrosis and cancer.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 35 Gatehouse Drive, A2
  • Waltham, MA 02451
  • United States
+1 (781) 000-0000

Morphic Therapeutic Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Morphic Therapeutic Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$32.37 $31.55 $9.90 - $36.65 $1.01B 31.1M 127K -$1.53

Morphic Therapeutic Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 635,652 271,351
Revenue 39,044 16,977 3,358 0
EBITDA (48,778) (46,261) (24,163) (16,500)
Net Income (47,081) (43,328) (23,831) (16,920)
Total Assets 221,578 247,435 189,305 23,242
Total Debt 0 0 0 630
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Morphic Therapeutic Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Morphic Therapeutic‘s full profile, request access.

Request a free trial

Morphic Therapeutic Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Morphic Holding Inc is a biopharmaceutical company applying its insights into integrins to discover and develop a pipeli
Drug Discovery
Waltham, MA
83 As of 2020
00000
00000000000 00000

0000000

or sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna
0000 000000000
Copenhagen North, Denmark
00 As of 0000
00000
0000 0000-00-00
00000000 00000

00000000

sequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla
0000000000000
Norcross, GA
0 As of 0000
000000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Morphic Therapeutic Competitors (28)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Galecto Formerly VC-backed Copenhagen North, Denmark 00 00000 00000000 00000
00000000 000000000 Corporation Norcross, GA 0 000000000000
00000 000000000000 Venture Capital-Backed South San Francisco, CA 00 00000 00000000000 00000
0000000 0000000000 Formerly VC-backed Toronto, Canada 0 00.000 000000&0 00.000
000000000 00000000 Venture Capital-Backed Salt Lake City, UT 000 00000 00000000000 00000
You’re viewing 5 of 28 competitors. Get the full list »

Morphic Therapeutic Executive Team (8)

Name Title Board Seat Contact Info
Praveen Tipirneni MD President & Chief Executive Officer
Marc Schegerin Chief Financial Officer, Finance & Chief Operating Officer, Operations
Robert Farrell Jr. Vice President, Finance & Operations and Treasurer
Bruce Rogers Ph.D Chief Scientific Officer
Alexey Lugovskoy Ph.D Chief Development Officer
You’re viewing 5 of 8 executive team members. Get the full list »

Morphic Therapeutic Board Members (14)

Name Representing Role Since
Amir Nashat Ph.D Polaris Partners Board Member 000 0000
Gustav Christensen Morphic Therapeutic Board Member 000 0000
Joseph Slattery Self Board Member 000 0000
Martin Edwards MD Morphic Therapeutic Board Member 000 0000
Nilesh Kumar Ph.D Novo Holdings Board Member 000 0000
You’re viewing 5 of 14 board members. Get the full list »

Morphic Therapeutic Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Morphic Therapeutic Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Morphic Therapeutic‘s full profile, request access.

Request a free trial